Uppsala University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
40
About the Report
About the Report
Summary
Uppsala University is an educational service provider that offers education and research services. The university offers master programs in the areas of science and technology, arts, law, medicine, languages, social sciences and theology. It conducts pharmaceutical research projects in the areas of ageing related diseases, children's diseases, cancer and other tumor diseases, cardiovascular diseases, behavioural science and ethics, biotechnology and bioinformatics, education research, psychiatry, and others. Uppsala University offers in-service training. The university conducts research in the areas of Biology, Computer Science, Physics, Earth Sciences, Chemistry, Mathematics and Engineering Sciences. It collaborates with the business community regarding both research and direct commercialization of results and ideas. Uppsala University is headquartered in Uppsala, Sweden.
Uppsala University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Uppsala University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Uppsala University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Uppsala University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Uppsala University, Medical Devices Deals, 2012 to YTD 2018 9
Uppsala University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Uppsala University, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Beactica Raises Funds through Venture Financing 11
Partnerships 12
BioArctic Enters into Research Collaboration Agreement with Uppsala University 12
BioArctic Enters into Research Agreement with Uppsala University 13
TARIS Biomedical Enters into Research Agreement with Uppsala Clinical Research Center 14
Double Bond Pharma Enters into Agreement with Uppsala University 15
Lidds Enters into Research Agreement with Uppsala University 16
Dicotyledon and Uppsala University Form Joint Venture 17
Licensing Agreements 18
Empros Pharma Enters into Licensing Agreement with Uppsala University 18
Uppsala University-Key Competitors 19
Uppsala University-Key Employees 20
Uppsala University-Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Government and Public Interest 22
Jul 02, 2018: Novel Pretargeted Radionuclide Therapy for HER2-Expressing Cancers Shows Promise 22
May 18, 2018: ContextVision deepens collaboration for development of digital lung pathology tool 23
Apr 06, 2018: A new class of antibiotics to combat drug resistance 24
Feb 14, 2018: Karolinska Institutet: Atlas of brain blood vessels provides fresh clues to brain diseases 26
Feb 06, 2018: New technology for accelerated wound healing discovered 27
Jan 18, 2018: New method to stop cells dividing could help fight cancer 28
Jan 17, 2018: New way to stop the growth of breast cancer cells 29
Nov 20, 2017: Oncotarget: Researchers Identify a Potential Molecular Trigger for Invasiveness in Prostate Cancer Cells 30
Oct 31, 2017: University of Copenhagen: Researchers map trends in drug development 31
Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 32
Jul 11, 2017: Shortcut Method in Drug Development 35
May 19, 2017: Mislocalized calcium channel causes insulin secretion defect in diabetes 36
Apr 25, 2017: Potential new treatment for kidney failure in cancer patients 37
Jan 16, 2017: New Research Study Creates New Opportunities for Treating Brain Diseases 38
Product News 39
Jan 12, 2017: Inhibition of EZH2 might be new therapy of multiple myeloma 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Figure
List of Figures
Uppsala University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Uppsala University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Uppsala University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Uppsala University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Uppsala University, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Uppsala University, Pharmaceuticals & Healthcare, Key Facts 2
Uppsala University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Uppsala University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Uppsala University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Uppsala University, Deals By Therapy Area, 2012 to YTD 2018 8
Uppsala University, Medical Devices Deals, 2012 to YTD 2018 9
Uppsala University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Beactica Raises Funds through Venture Financing 11
BioArctic Enters into Research Collaboration Agreement with Uppsala University 12
BioArctic Enters into Research Agreement with Uppsala University 13
TARIS Biomedical Enters into Research Agreement with Uppsala Clinical Research Center 14
Double Bond Pharma Enters into Agreement with Uppsala University 15
Lidds Enters into Research Agreement with Uppsala University 16
Dicotyledon and Uppsala University Form Joint Venture 17
Empros Pharma Enters into Licensing Agreement with Uppsala University 18
Uppsala University, Key Competitors 19
Uppsala University, Key Employees 20
Uppsala University, Subsidiaries 21
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.